Drugs · acquisition-cost intelligence
EQUATE MUCUS D
Guaifenesin and Pseudoephedrine HCl· ingredient guaifenesinSympathomimetics· GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1; GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.41980
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other guaifenesin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Adult Tussin | $0.01815 | −$0.40170 |
| Leader Adult Tussin Mucus and Chest Congestion 541 | $0.02236 | −$0.39740 |
| Guaifenesin 200mg | $0.03140 | −$0.38840 |
| Always Save Chest Congestion Relief GUAF | $0.06723 | −$0.35260 |
| Always Save Mucus Relief PE | $0.08718 | −$0.33260 |
| 12 Hour Mucus Relief | $0.29751 | −$0.12230 |
| equate mucus d | $0.36492 | −$0.05490 |
| basic care mucus er max | $0.44813 | +$0.02830 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.